Money: Aurora Cannabis appoints Nelson Peltz as adviser - PressFrom - Canada
  •   
  •   
  •   

MoneyAurora Cannabis appoints Nelson Peltz as adviser

16:10  13 march  2019
16:10  13 march  2019 Source:   msn.com

Police shut down Toronto warehouse supplying illicit cannabis products

Police shut down Toronto warehouse supplying illicit cannabis products "This is the first time we've seen a significant quantity of edibles seized," said York police Const. Andy Pattenden.

Aurora Cannabis announced Wednesday that it has appointed longtime activist investor Nelson Peltz as a strategic advisor . Peltz will "work collaboratively and strategically to explore potential partnerships that would be the optimal strategic fit for successful entry into each of Aurora 's contemplated market

Nelson Peltz (born June 24, 1942) is an American billionaire businessman and investor. He is a founding partner, together with Peter W. May and Edward P. Garden, of Trian Fund Management, an alternative investment management fund based in New York.

EDMONTON - Aurora Cannabis shares are up following news that it has appointed U.S. billionaire Nelson Peltz as a strategic adviser and given him the option to buy a stake in the company.

The Edmonton-based cannabis company says it has granted Peltz options to purchase nearly 20 million common shares at $10.34 per share, slightly below Tuesday's closing price.

The shares were up more than 12 per cent in early trading, rising to $11.97 — up from Tuesday's close of $10.64.

Peltz is CEO and founding partner of Trian Fund Management LP, a multi-billion dollar investment management firm.

Aurora Cannabis appoints Nelson Peltz as adviser© Provided by thecanadianpress.com Nelson Peltz of Trian Group, Heinz's second-largest investor, addresses shareholders during the annual meeting in Pittsburgh on August 16, 2006. He also serves as the non-executive chairman of The Wendy's Company and director of The Procter & Gamble Company, and was previously a director of H.J. Heinz Company and Mondelez International Inc.

Why Surging Pot Demand Has Aurora Cannabis Inc (TSX:ACB) CEO Losing Sleep

Why Surging Pot Demand Has Aurora Cannabis Inc (TSX:ACB) CEO Losing Sleep Aurora Cannabis Inc's (TSX:ACB)(NYSE:ACB) stock price is surging, but CEO Terry Booth is losing sleep over this one thing.

CNBC's Bertha Coombs reports that Procter & Gamble has granted Nelson Peltz a seat on its board of directors.

Nelson Peltz hates being called an activist, let alone a corporate raider. The longtime financier, who has made his name investing in companies like Heinz and DuPont and agitating for change, prefers to think of himself as a “constructivist,” someone who doesn’t necessarily seek to break up a company

Aurora said it will work with Peltz to explore potential partnerships for entry into certain market segments, and he will also advise on the cannabis producer's global expansion strategy.

Peltz said Aurora has a "solid execution track record" and is poised to go to the "next level" across a range of industry verticals.

"I also believe that Canadian licensed producers, and Aurora in particular, are well positioned to lead in the development of the international cannabis industry as regulations evolve, with a strong, globally replicable operating model," Peltz said in a statement.

The options granted to Peltz will become effective gradually over a four-year period on a quarterly basis, with accelerated vesting if specified events occur. Those events include the consummation of certain transactions and the closing price of Aurora's common shares reaching certain levels.

Companies in this story: (TSX: ACB)

Are you on LinkedIn? Follow Microsoft News Canada and keep up with the latest industry news, career, jobs and tech updates. Connect with us now!

Tilray shares rise as pot firm reports higher selling prices.
Tilray Inc. shares rose in post-market trading after the company reported revenue that beat estimates and a higher average selling price, though investor enthusiasm was dampened by weaker margins and a wider-than-expected loss. The cannabis producer’s fourth-quarter revenue was $15.5 million, triple the year-ago period and ahead of the average analyst estimate of $15.1 million, as it sold more pot at higher prices. However, it lost $31 million in the quarter, significantly more than the $3 million lost a year earlier, amid higher operating expenses. Key InsightsTilray reported an average net selling price per gram of $7.

—   Share news in the SOC. Networks

Topical videos:

usr: 4
This is interesting!